Inflammatory Bowel Disease Cohort in Nantes

Sponsor
Nantes University Hospital
Study ID
NCT06256393
Status
Recruiting
Apply to this trial

Conditions

  • Inflammatory Bowel Diseases

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Collection of biological samples — OTHER
    Collection of blood samples and intestinal biopsies during a surgery or colonoscopy for disease relapse

Study Details

The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease

Key Dates

First listed
Feb 13, 2024
Start date
Feb 4, 2025
Status verified
Feb 2025
Primary completion
Feb 29, 2028
Completion
Feb 28, 2031

Study Design

Enrollment
360 participants (estimated)

Arms

  • Arm: Patients
    Patients of both sexes, over 18 years of age, with an established diagnosis of IBD (Crohn's desease, ulcerative colitis, unclassified IBD or chronic pouchitis) will be eligible for inclusion in a consultation to schedule surgery or colonoscopy for disease relapse (at diagnosis or prior to initiation of treatment), irrespective of treatment received

Primary Outcome Measure

Proportion of patients who succeed in their therapeutic strategy [ Time Frame: One year after inclusion ]

Central Contacts

Related Studies